Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases. | Biomedicines | 2022 | 36140383 | PubTator, text mining | PubMed |
| Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease. | Front Pharmacol | 2022 | 36120335 | PubTator, text mining | PubMed |
| Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease. | Dose Response | 2022 | 36118679 | PubTator, text mining | PubMed |
| Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis. | Front Med (Lausanne) | 2022 | 36117980 | PubTator, text mining | PubMed |
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. | Redox Biol | 2022 | 36108528 | PubTator, text mining | PubMed |
| Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review. | J Oncol | 2022 | 36106333 | PubTator, text mining | PubMed |
| The promising significance of liraglutide combined with dapagliflozin or empagliflozin in the prevention of early diabetic nephropathy. | Am J Transl Res | 2022 | 36105007 | PubTator, text mining | PubMed |
| Absence of long-term changes in urine biomarkers after AKI: findings from the CRIC study. | BMC Nephrol | 2022 | 36100915 | PubTator, text mining | PubMed |
| Dexmedetomidine and acute kidney injury following cardiac surgery in pediatric patients-An updated systematic review and meta-analysis. | Front Cardiovasc Med | 2022 | 36093139 | PubTator, text mining | PubMed |
| Advances in the study of subclinical AKI biomarkers. | Front Physiol | 2022 | 36091391 | PubTator, text mining | PubMed |
| Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets. | Int J Mol Sci | 2022 | 36077044 | PubTator, text mining | PubMed |
| Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study. | Adv Ther | 2022 | 36070133 | PubTator, text mining | PubMed |
Measurement of Serum Levels of 5 Amino Acids and Dimethylamine Using Liquid Chromatography-Tandem Mass Spectrometry in Patients without Septic Associated Acute Kidney Injury and with Septic Associated Acute Kidney Injury Requiring Continuous Renal Replacement Therapy. | Med Sci Monit | 2022 | 36068726 | PubTator, text mining | PubMed |
| FABP4 in obesity-associated carcinogenesis: Novel insights into mechanisms and therapeutic implications. | Front Mol Biosci | 2022 | 36060264 | PubTator, text mining | PubMed |
| Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression. | Front Pharmacol | 2022 | 36059949 | PubTator, text mining | PubMed |
| Identification of novel tumor microenvironment-associated genes in gastric cancer based on single-cell RNA-sequencing datasets. | Front Genet | 2022 | 36046240 | PubTator, text mining | PubMed |
| Intestinal cellular heterogeneity and disease development revealed by single-cell technology. | Cell Regen | 2022 | 36045190 | PubTator, text mining | PubMed |
| Single-cell profiling of environmental enteropathy reveals signatures of epithelial remodeling and immune activation. | Sci Transl Med | 2022 | 36044598 | PubTator, text mining | PubMed |
| The Use of Renal Biomarkers in Pediatric Cardiac Patients With Acute Kidney Injury. | J Pediatr Pharmacol Ther | 2022 | 36042964 | PubTator, text mining | PubMed |
| Culture-Associated DNA Methylation Changes Impact on Cellular Function of Human Intestinal Organoids. | Cell Mol Gastroenterol Hepatol | 2022 | 36038072 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=37